iCardiac Technologies

About:

iCardiac Technologies is a laboratory that develops cardiac safety biomarkers which provide assessments of drugs in development.

Website: http://icardiac.com

Twitter/X: iCardiac

Top Investors: Norwest Venture Partners, Advantage Capital, Stonehenge Capital, Trillium Group, Stonehenge Growth Capital

Description:

iCardiac Technologies, Inc. develops cardiac safety biomarkers. The company offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers that delivers assessment of the cardiac safety profile of drugs in development. Its technology is used in cardiac clinical trials conducted by pharmaceutical, biotechnology, and medical device companies. The company’s services include scientific and medical consultation, study design, data and project management, ECG analysis, statistical reporting, data submission, and interface with the regulators. iCardiac Technologies, Inc. was founded in 2006 and is headquartered in Rochester, New York.